Miss Charlie Ffrench
Grant-Funded Researcher (A)
Centre for Cancer Biology
College of Health
| Date | Position | Institution name |
|---|---|---|
| 2026 - 2027 | Grant-Funded Researcher (A) | University of Adelaide |
| 2020 - 2024 | Laboratory Scientist | Australian Clinical Laboratory - Ashford Hospital |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2025 | Award | The Austalasian Summit on Vascular Biology and Microcirculation - Australian Vascular Biology Society student oral presentation winner | Centre for Cancer Biology | Australia | - |
| 2025 | Award | $500 Travel Bursary - Australian Vascular Biology Society | Centre for Cancer Biology | Australia | - |
| 2024 | Award | Tour De Cure $10,000 postgraduate PhD Scholarship | Centre for Cancer Biology | Australia | - |
| 2023 | Award | Australian Society for Medical Research Conference - Best oral presentation by a postgraduate student in the field of cancer research | Centre for Cancer Biology | Australia | - |
| 2023 | Award | University of South Australia Vice Chancellor and Presidents $10,000 Scholarship | Centre for Cancer Biology | Australia | - |
| 2023 | Award | The Australian Rotary Health / Phillip and Glenis Hayes PhD Scholarship Top-up | Centre for Cancer Biology | Australia | - |
| 2022 | Award | University of South Australia Postgraduate Research Award - RTP | University of South Australia | Australia | - |
| 2022 | Award | Australian Society for Medical Research Conference - Best Honours oral presentation | University of South Australia | Australia | - |
| 2021 | Award | Martin Hansen Award | University of South Australia | Australia | - |
| 2020 | Award | University Merit Award | University of South Australia | Australia | - |
| 2018 | Award | University Merit Award | University of South Australia | Australia | - |
| 2018 | Award | University Merit Award | University of South Australia | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2022 - 2026 | University of South Australia | Australia | Doctor of Philosophy - Cancer Research |
| 2018 - 2021 | University of South Australia | Australia | Bachelor of Laboratory Medicine (Honours) |
| Year | Citation |
|---|---|
| 2024 | Ffrench, C. B., Min, K. K. M., DeNichilo, M., Cockshell, M. P., Dorward, E. L., Thompson, E. J., . . . Bonder, C. S. (2024). Desmoglein-2 is a regulator of pancreatic ductal adenocarcinoma progression. In CANCER RESEARCH Vol. 84 (pp. 3 pages). MA, Boston: AMER ASSOC CANCER RESEARCH. DOI |
| Date | Topic | Location | Name |
|---|---|---|---|
| 2024 - 2027 | Pancreatic cancer development | Centre for Cancer Biology | Emma Dorward |
| 2023 - 2027 | Cancer development and progression | Centre for Cancer Biology | Placement students |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2022 - 2025 | Member | Adelaide Immunology Retreat - Australian and New Zealand Society for Immunology | Centre for Cancer Biology | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2024 - ongoing | Member | American Association for Cancer Research | United States |
| 2023 - ongoing | Member | Australian Vascular Biology Society | Australia |
| 2021 - ongoing | Member | Australian and New Zealand Society for Immunology | Australia |
| 2021 - ongoing | Member | Australian Society for Medical Research | Australia |
| Date | Topic | Presented at | Institution | Country |
|---|---|---|---|---|
| 2025 - ongoing | Regulators of vasculature development in pancreatic cancer | The Australasian Summit on Vascular Biology and Microcirculation 2025 | Centre for Cancer Biology | New Zealand |
| 2025 - ongoing | Desmoglein-2 is a regulator of pancreatic ductal adenocarcinoma progression | Australian Islet Study Group Meeting 2025 | Centre for Cancer Biology | Australia |
| 2024 - ongoing | Desmoglein-2 is a regulator of pancreatic ductal adenocarcinoma progression | American Association for Cancer Research - Special Conference: Advances in pancreatic cancer research | Centre for Cancer Biology | United States |
| 2024 - ongoing | Investigating the molecular mechanisms by which desmoglein-2 contributes to pancreatic ductal adenocarcinoma development and progression | Adelaide Immunology Retreat - Australian and New Zealand Society for Immunology | Centre for Cancer Biology | Australia |
| 2024 - ongoing | Desmoglein-2 is a regulator of pancreatic ductal adenocarcinoma progression | Australian Society for Medical Research 2024 | Centre for Cancer Biology | Australia |
| 2023 - ongoing | Regulators of vasculogenic mimicry in pancreatic cancer | The Australian Atherosclerosis Society (AAS) – Australian and New Zealand Microcirculation Society (ANZMS) – Australian Vascular Biology Society (AVBS) Annual Scientific Meeting | Centre for Cancer Biology | Australia |
| 2023 - ongoing | Investigating the molecular mechanisms by which desmoglein-2 contributes to pancreatic ductal adenocarcinoma development and progression | Adelaide Immunology Retreat - Australian and New Zealand Society for Immunology | Centre for Cancer Biology | Australia |
| 2023 - ongoing | Investigating the molecular mechanisms by which desmoglein-2 contributes to pancreatic ductal adenocarcinoma development and progression | Australian Society for Medical Research 2023 | Centre for Cancer Biology | Australia |
| 2022 - ongoing | Vasculogenic mimicry in cancer: a deadly imposter | 10th Garvan Signalling Symposium | Centre for Cancer Biology | Australia |
| 2022 - ongoing | Regulators of vasculogenic mimicry in pancreatic cancer | Adelaide Immunology Retreat - Australian and New Zealand Society for Immunology | Centre for Cancer Biology | Australia |
| 2022 - ongoing | Regulators of vasculogenic mimicry in pancreatic cancer | Australian Society for Medical Research 2022 | Centre for Cancer Biology | Australia |